Benchmark ultra reagents and consumables

Ended Awarded Last action

Contract number
HHSN26100001
Awardee
Awarding agency
Obligated
$31,485

Award facts

Opportunity
Contract value 100% obligated
$31,485.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$969
Original award $32,454

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on December 16, 2014, with a ceiling value of $31,485.04 for benchmark ultra reagents and consumables under firm fixed-price terms.

Place of performance is Castleton, IN 46256. The order is scheduled for ultimate completion on February 15, 2015. No set-aside was used in this award.

Quick answers

Who was awarded contract HHSN26100001?

HHSN26100001 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on December 16, 2014.

How much is contract HHSN26100001 worth?

The government has obligated $31,485 on HHSN26100001.

Is contract HHSN26100001 an order under another contract?

Yes. HHSN26100001 is a delivery order under HHSN261201500001I, an indefinite delivery contract.

Was contract HHSN26100001 competed?

The extent of competition for HHSN26100001 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award